Letters Mibefradil was not rushed to market in United States BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7213.852a (Published 25 September 1999) Cite this as: BMJ 1999;319:852 Article Related content Metrics Responses Peer review Related articles Letter FDA approves drugs even when experts on its advisory panels raise safety questions Published: 03 April 1999; BMJ 318 doi:10.1136/bmj.318.7188.944a See more Sixty seconds on . . . 10 000 steps BMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598 Scarlett McNally: Enabling active travel can improve the UK’s health BMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522 Scarlett McNally: Boosting swimming for health and joy BMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393 Variability in blood pressure could help predict heart attack and stroke risk, researchers say BMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
